» Articles » PMID: 35551638

Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients

Overview
Journal Infect Dis Ther
Date 2022 May 13
PMID 35551638
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Infections caused by Gram-negative bacteria, in particular carbapenem-resistant organisms (CRO), pose a great threat to liver transplant (LT) recipients. Understanding the risk factors for Gram-negative and CRO infections and the drug resistance of corresponding bacteria will help guide the prevention and treatment of these infections.

Methods: Data on the composition, distribution and drug resistance of Gram-negative bacteria and CRO among LT recipients were collected. The risk factors for Gram-negative and CRO infections were identified via univariate and multivariate analysis.

Results: A total of 45 episodes of Gram-negative infection, including 20 episodes of CRO infection, occurred in 19.9% (27/136) of LT recipients. Klebsiella pneumoniae was the dominant pathogenic bacteria (14/45; 31.1%). The most common site of infection was the abdominal cavity/bile duct (11/27; 40.7%). Eleven (8.1%) patients died within 2 months after LT, and two deaths were related to Gram-negative infection. Gram-negative bacteria were relatively sensitive to tigecycline and polymyxin B, with resistance of 26.7 and 11.1%, respectively. CRO had lower resistance to ceftazidime/avibactam (45.5%) and polymyxin B (10%). A univariate analysis showed that male sex, infection within 2 months prior to LT, duration of surgery ≥ 400 min, reoperation, indwelling urethral catheter use ≥ 3 days and elevated alanine aminotransferase on day 1 post-LT were associated with Gram-negative infection. Multivariate logistic regression analysis revealed that infection within 2 months prior to LT [odds ratio (OR) = 4.426, 95%CI: 1.634-11.99, P = 0.003], duration of surgery ≥ 400 min [OR = 3.047, 95%CI: 1.194-7.773, P = 0.02] and indwelling urethral catheter use ≥ 3 days [OR = 5.728, 95%CI: 1.226-26.763, P = 0.026] were independent risk factors for Gram-negative infection after LT, and that only carbapenem use ≥ 3 days within 15 days prior to infection [OR = 14, 95%CI: 1.862-105.268, P = 0.01] was related to the occurrence of CRO infections.

Conclusion: The incidence of Gram-negative and CRO infections was high in the early post-LT period. The most common infection site was the abdominal cavity/bile duct, and the dominant pathogen was K. pneumoniae. Patients with infections within 2 months prior to LT, prolonged surgery time or delayed urethral catheter removal were prone to Gram-negative infection. Carbapenem exposure was correlated with CRO infections.

Citing Articles

Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review.

Gatti M, Pea F Front Antibiot. 2025; 3():1426753.

PMID: 39816245 PMC: 11732092. DOI: 10.3389/frabi.2024.1426753.


Antibiotic Stewardship Based on Colonization with Multi-Drug-Resistant Bacteria in Liver Transplantation: A Narrative Review.

Zuccaro V, Giordani P, Binda F, Asperges E, Farina E, Vigano M Microorganisms. 2025; 12(12.

PMID: 39770696 PMC: 11728255. DOI: 10.3390/microorganisms12122493.


Role of a Real-Time TDM-Based Expert Clinical Pharmacological Advice Program in Optimizing the Early Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Beta-Lactams among Orthotopic Liver Transplant Recipients with Documented....

Gatti M, Rinaldi M, Laici C, Siniscalchi A, Viale P, Pea F Antibiotics (Basel). 2023; 12(11).

PMID: 37998801 PMC: 10668725. DOI: 10.3390/antibiotics12111599.


Characteristics of Gram-positive cocci infection and the therapeutic effect after liver transplantation.

Wu X, Wu L, Shu L, Xie C, Wan Q Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(5):707-715.

PMID: 37539573 PMC: 10930403. DOI: 10.11817/j.issn.1672-7347.2023.220631.


Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review.

Dolci G, Burastero G, Paglia F, Cervo A, Meschiari M, Guaraldi G Microorganisms. 2023; 11(6).

PMID: 37375108 PMC: 10304660. DOI: 10.3390/microorganisms11061606.

References
1.
Freire M, Pierrotti L, Villela Soares Oshiro I, Bonazzi P, Oliveira L, Machado A . Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes. Liver Transpl. 2015; 22(5):615-26. DOI: 10.1002/lt.24389. View

2.
Kalpoe J, Sonnenberg E, Factor S, Del Rio Martin J, Schiano T, Patel G . Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2012; 18(4):468-74. DOI: 10.1002/lt.23374. View

3.
Shafiekhani M, Mirjalili M, Vazin A . Prevalence, Risk Factors And Treatment Of The Most Common Gram-Negative Bacterial Infections In Liver Transplant Recipients: A Review. Infect Drug Resist. 2020; 12:3485-3495. PMC: 6859291. DOI: 10.2147/IDR.S226217. View

4.
Freire M, Soares Oshiro I, Bonazzi P, Guimaraes T, Figueira E, Bacchella T . Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes. Liver Transpl. 2013; 19(9):1011-9. DOI: 10.1002/lt.23682. View

5.
Pereira M, Scully B, Pouch S, Uhlemann A, Goudie S, Emond J . Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015; 21(12):1511-9. PMC: 4896355. DOI: 10.1002/lt.24207. View